| Names | |
|---|---|
| IUPAC name 2-[(5-Amino-5-carboxypentyl)amino]pentanedioic acid[1] | |
| Identifiers | |
| |
3D model (JSmol) | |
| ChEBI | |
| ChemSpider |
|
| DrugBank |
|
| KEGG |
|
| MeSH | saccharopine |
| UNII | |
| |
| |
| Properties | |
| C11H20N2O6 | |
| Molar mass | 276.289 g·mol−1 |
| Related compounds | |
Related alkanoic acids | |
Related compounds | Palmitoylethanolamide |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Saccharopine is an intermediate in themetabolism of amino acidlysine. It is a precursor of lysine in thealpha-aminoadipate pathway which occurs infungi andeuglenids. In mammals andseed plants saccharopine is an intermediate in the degradation of lysine, formed by condensation of lysine andalpha-ketoglutarate.
The reactions involved, catalysed bysaccharopine dehydrogenases, are:
Saccharopinuria (high amounts of saccharopine in the urine) and saccharopinemia (an excess of saccharopine in the blood) are conditions present in some inherited disorders of lysine degradation.
Saccharopine was first isolated in 1961 frombaker's yeast (Saccharomyces cerevisiae, hence the name) by Darling and Larsen.[2]